Neoadjuvant Listeria or Daratumumab in Prostate Cancer

NCT03035357 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI's Request

Conditions

Malignant Neoplasms of Male Genital Organs
Prostate Cancer

Interventions

DRUG: Daratumumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]